Literature DB >> 3744857

Reconstruction of the subglottic larynx with a myoperiosteal flap: clinical and experimental study.

M Friedman, V Grybauskas, D M Toriumi, A Kaplan, A Seiden.   

Abstract

The literature describes numerous techniques for reconstruction of the subglottic larynx. The use of rigid bone grafts or flaps has been associated with problems because the rigid bone cannot conform to the defect and form an airtight seal. We have performed subglottic reconstruction using the sternocleidomastoid myoperiosteal flap with very optimistic results on long-term follow up. The sternocleidomastoid myoperiosteal flap is a relatively simple procedure that can be used for a large variety of defects. The pliable periosteal flap used for closing the defect can be molded over a stent to form an airtight seal. We have demonstrated bone formation in the periosteum which is crucial to the stability of the airway and long-term success of the procedure. The sternocleidomastoid myoperiosteal flap yields a pliable, durable tissue capable of airtight closure and a tension-free suture line. This technique will make the closure of subglottic defects a much more practical task.

Entities:  

Mesh:

Year:  1986        PMID: 3744857     DOI: 10.1002/hed.2890080409

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  3 in total

1.  Two-stage repair of extensive subglottic tracheal stenosis.

Authors:  T Somers; J Marquet; E Offeciers
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction.

Authors:  Fenglin Sun; Xuezhong Li; Dapeng Lei; Tong Jin; Dayu Liu; Hui Zhao; Qiuan Yang; Guojun Li; Xinliang Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  Sternocleidomastoid flap for pedicled reconstruction in head & neck surgery- revisiting the anatomy and technique.

Authors:  Apurva Srivastava; Tarun Kumar; Shashi Kant Pandey; Ram Chandra Shukla; Esha Pai; Manoj Pandey
Journal:  World J Surg Oncol       Date:  2021-12-20       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.